Menaka Bhor

959 total citations
52 papers, 623 citations indexed

About

Menaka Bhor is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Menaka Bhor has authored 52 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 26 papers in Genetics and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Menaka Bhor's work include Hemoglobinopathies and Related Disorders (18 papers), Iron Metabolism and Disorders (16 papers) and Platelet Disorders and Treatments (10 papers). Menaka Bhor is often cited by papers focused on Hemoglobinopathies and Related Disorders (18 papers), Iron Metabolism and Disorders (16 papers) and Platelet Disorders and Treatments (10 papers). Menaka Bhor collaborates with scholars based in United States, United Kingdom and Switzerland. Menaka Bhor's co-authors include Jincy Paulose, Nirmish Shah, Hüseyin Yüce, Lin Xie, Debra A. Patt, Richard Barron, Gary H. Lyman, Neelima Denduluri, Yunfei Wang and Xiaoyan Li and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Menaka Bhor

50 papers receiving 605 citations

Peers

Menaka Bhor
Wasil Jastaniah Saudi Arabia
Payal Desai United States
Karen Sweiss United States
Farrukh Shah United Kingdom
Binay Kumar Shah United States
Gabriela Hobbs United States
S J Lee United States
Sharon Avery Australia
Bruno Émond United States
Thuan Chong Quah Singapore
Wasil Jastaniah Saudi Arabia
Menaka Bhor
Citations per year, relative to Menaka Bhor Menaka Bhor (= 1×) peers Wasil Jastaniah

Countries citing papers authored by Menaka Bhor

Since Specialization
Citations

This map shows the geographic impact of Menaka Bhor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Menaka Bhor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Menaka Bhor more than expected).

Fields of papers citing papers by Menaka Bhor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Menaka Bhor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Menaka Bhor. The network helps show where Menaka Bhor may publish in the future.

Co-authorship network of co-authors of Menaka Bhor

This figure shows the co-authorship network connecting the top 25 collaborators of Menaka Bhor. A scholar is included among the top collaborators of Menaka Bhor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Menaka Bhor. Menaka Bhor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Prateek, Gary W. Falk, Menaka Bhor, et al.. (2023). Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States. Journal of health economics and outcomes research. 51–58. 2 indexed citations
2.
Sharma, Prateek, Gary W. Falk, Menaka Bhor, et al.. (2023). Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States. Journal of health economics and outcomes research. 10(1). 51–58. 6 indexed citations
3.
Shafrin, Jason, Howard Thom, Edna Keeney, et al.. (2021). The impact of vaso-occlusive crises and disease severity on quality of life and productivity among patients with sickle cell disease in the US. Current Medical Research and Opinion. 37(5). 761–768. 6 indexed citations
4.
Lee, Soyon, et al.. (2020). <p>Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review</p>. International Journal of General Medicine. Volume 13. 361–377. 26 indexed citations
5.
Barner, Jamie C., et al.. (2020). Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study. Journal of health economics and outcomes research. 7(1). 94–101. 9 indexed citations
6.
Rizio, Avery A., Menaka Bhor, Xiaochen Lin, et al.. (2020). The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease. Quality of Life Research. 29(6). 1533–1547. 43 indexed citations
7.
Joseph, George J, Dominick Latrémouille-Viau, Patrick Gagnon‐Sanschagrin, et al.. (2019). Vaso-Occlusive Crises and Costs of Sickle Cell Disease from a Commercial Payer's Perspective. Blood. 134(Supplement_1). 3464–3464. 2 indexed citations
8.
Shah, Nirmish, Menaka Bhor, Lin Xie, et al.. (2019). Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study. Journal of health economics and outcomes research. 106–117. 2 indexed citations
9.
Kanter, Julie, Menaka Bhor, Xin Li, Yunfeng Li, & Jincy Paulose. (2019). High Healthcare Utilization in Adolescents with Sickle Cell Disease Prior to Transition to Adult Care: A Retrospective Study. Journal of health economics and outcomes research. 6(3). 174–184. 15 indexed citations
10.
Barner, Jamie C., et al.. (2019). PRO38 ASSOCIATION BETWEEN VASO-OCCLUSIVE CRISES AND OPIOID USE AMONG TEXAS MEDICAID RECIPIENTS WITH SICKLE CELL DISEASE. Value in Health. 22. S342–S342. 1 indexed citations
11.
Rizio, Avery A., et al.. (2019). PRO55 THE RELATIONSHIP BETWEEN VASO-OCCLUSIVE CRISES AND WORK PRODUCTIVITY IMPAIRMENT IN PATIENTS WITH SICKLE CELL DISEASE. Value in Health. 22. S345–S345. 1 indexed citations
12.
Shah, Nirmish, Ralph V. Boccia, Walter K. Kraft, et al.. (2019). PRO3 SUCCESSOR STUDY: TREATMENT AND HEALTH CARE RESOURCE UTILIZATION BY SICKLE CELL PATIENTS WHO PARTICIPATED IN THE SUSTAIN STUDY IN THE UNITED STATES. Value in Health. 22. S335–S335. 3 indexed citations
13.
Tremblay, Gabriel, Menaka Bhor, Anuja Roy, et al.. (2017). Cost-Consequence Model Comparing Eltrombopag and Romiplostim for Pediatric Patients with Previously-Treated Chronic Immune Thrombocytopenia. Blood. 130. 2146–2146. 1 indexed citations
14.
15.
16.
Patt, Debra A., et al.. (2014). A Real-World Observational Study of Patients with Advanced Melanoma Receiving First-Line Ipilimumab in a Community Practice Setting. Journal of Cancer Therapy. 5(12). 1049–1058. 4 indexed citations
17.
Tundia, Namita, Menaka Bhor, Amy Duhig, et al.. (2012). PMH58 Impact of Positive and Negative Symptoms and Cognitive Impairment on Health Outcomes and Healt Care Resource Utilization in European Patients with Schizophrenia. Value in Health. 15(4). A92–A92. 1 indexed citations
18.
Vogelzang, Nicholas J., Menaka Bhor, Zhimei Liu, Rahul Dhanda, & Thomas E. Hutson. (2012). Everolimus vs. Temsirolimus for Advanced Renal Cell Carcinoma: Use and Use of Resources in the US Oncology Network. Clinical Genitourinary Cancer. 11(2). 115–120. 15 indexed citations
19.
Simpson, Kit N., Robert W. Baran, Kevin W. Garren, et al.. (2011). Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data. Cost Effectiveness and Resource Allocation. 9(1). 5–5. 7 indexed citations
20.
Bhor, Menaka & Holly L. Mason. (2006). Development and validation of a scale to assess attitudes of health care administrators toward the use of e-mail communication between patients and physicians. Research in Social and Administrative Pharmacy. 2(4). 512–532. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wasil Jastaniah Breakdown of academic impact, for papers by Payal Desai Breakdown of academic impact, for papers by Karen Sweiss Breakdown of academic impact, for papers by Farrukh Shah Breakdown of academic impact, for papers by Binay Kumar Shah Breakdown of academic impact, for papers by Gabriela Hobbs Breakdown of academic impact, for papers by S J Lee Breakdown of academic impact, for papers by Sharon Avery Breakdown of academic impact, for papers by Bruno Émond Breakdown of academic impact, for papers by Thuan Chong Quah
Rankless by CCL
2026